Journals / Türk Toraks Dergisi / 2014 / Cilt: 15 - Sayı: 4

A Rare adverse event induced by theophylline: Epilepsy

Pages
172–174
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite its poor effcacy, theophylline, which is a methylxanthine derivative, is being commonly used for the treatment of chronic obstructive pulmonary disease (COPD) worldwide for many years due to its low cost.
📊
Key Findings & Data:This drug with bronchodilator activity must be carefully used in the elderly.
💡
Conclusion & Impact:In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Despite its poor effcacy, theophylline, which is a methylxanthine derivative, is being commonly used for the treatment of chronic obstructive pulmonary disease (COPD) worldwide for many years due to its low cost. This drug with bronchodilator activity must be carefully used in the elderly. In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.

🔖

Cite This Article

BATUM, Ö., BATUM, M. (2014). A Rare adverse event induced by theophylline: Epilepsy. Türk Toraks Dergisi, Cilt: 15 - Sayı: 4, 172–174. https://ajindex.com/articles/329479

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Charehsaz M, Gürbay A, Karakılıç E, Şahin G. Theophylline: Ad - verse effects, poisoning and treatment approaches. J Clin Anal Med 2011;2:157-63. [CrossRef] 2. Abernethy DR, Arnold GJ, Azarnoff D, editors. Mosby’s Drug Consult. St. Louis: Mosby Inc, 2002. 3. Sifton DJ, editor. Physicians Desk Reference. 57th ed. Montvale: Thomson PDR; 2003. 4. Abernethy DR, Arnold GJ, Azarnoff D, editors. Mosby’s Drug Consult. St. Louis: Mosby Inc, 2002. 5. Barnes PJ. Theophylline in chronic obstructive pulmonary disease: new horizons. Proc Am Thorac Soc 2005;2:334-40. [CrossRef] 6. Kayaalp SO, editor. Medical Pharmacology Regarding the Ra - tional Treatment.11th ed. Ankara: Hacettepe-Taş Kitapçılık, 2005. 7. Rotella DP. Phosphodiesterase enzymes- Target overwiev. Touch Briefngs. Drug Discovery. 2007;22-3. 8. Yaguchi M, Yaguchi H. A case of theophylline-associated sei- zures with postictal fever and postictal pleocytosis. Brain Nerve 2010;62:1089-93. 9. Boison D. Methylxanthines, seizures, and excitotoxicity. Handb Exp Pharmacol 2011:251-66. 10. Koizumi S, Saito K. Theophylline-induced changes in mouse electroencephalograms Brain Dev 2010;32:818-20. [CrossRef]